×
About 908 results

ALLMedicine™ Diabetic Foot Infections Center

Research & Reviews  230 results

Extra-pulmonary applications of procalcitonin: an updated literature review.
https://doi.org/10.1080/14737159.2022.2094705
Expert Review of Molecular Diagnostics; Atallah CJ, Panossian VS et. al.

Jun 28th, 2022 - : Procalcitonin (PCT) is a biomarker with established performance in the differentiation between bacterial and viral infections, predominantly in pulmonary infections, as well as the diagnosis and prognosis of bacterial sepsis. However, the role o...

The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates
https://clinicaltrials.gov/ct2/show/NCT03978715

Jun 22nd, 2022 - This will be a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investig...

Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilo...
https://doi.org/10.1097/SLA.0000000000005205
Annals of Surgery; Pham TT, Gariani K et. al.

May 28th, 2022 - The optimal duration of antibiotic therapy for soft-tissue infections of the diabetic foot (ST-DFI) remains unknown. We determine if antibiotic therapy after debridement for a short (10 days), compared with a long (20 days), duration for ST-DFI re...

Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)
https://clinicaltrials.gov/ct2/show/NCT05074147

May 16th, 2022 - The fight against multi-drug resistant bacteria is a global matter and a major health public issue. The excessive exposure of microorganisms to drugs increases their ability to develop survival mechanisms, causing an emerging threat and a health c...

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
https://clinicaltrials.gov/ct2/show/NCT05369052

May 11th, 2022 - Approximately 865 subjects (519 contezolid acefosamil/contezolid: 346 linezolid) will be enrolled with moderate or severe DFI that are confirmed or suspected to be due to a Gram-positive bacterial pathogen (MITT analysis set).

see more →

Guidelines  1 results

2012 Infectious Diseases Society of America clinical practice guideline for the diagnos...
https://doi.org/10.1093/cid/cis346
Clinical Infectious Diseases : an Official Publication Of... Lipsky BA, Berendt AR et. al.

May 24th, 2012 - Foot infections are a common and serious problem in persons with diabetes. Diabetic foot infections (DFIs) typically begin in a wound, most often a neuropathic ulceration. While all wounds are colonized with microorganisms, the presence of infecti...

see more →

Drugs  71 results see all →

Clinicaltrials.gov  25 results

The Effect of Implementing a Limb Loss Prevention Program on Amputation Rates
https://clinicaltrials.gov/ct2/show/NCT03978715

Jun 22nd, 2022 - This will be a retrospective chart review on patients admitted to Parkland Hospital with diabetic foot infections, ulcers, and bone injuries from 2005 (5 years prior to the start of the diabetic limb preservation team) to present day. The investig...

Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)
https://clinicaltrials.gov/ct2/show/NCT05074147

May 16th, 2022 - The fight against multi-drug resistant bacteria is a global matter and a major health public issue. The excessive exposure of microorganisms to drugs increases their ability to develop survival mechanisms, causing an emerging threat and a health c...

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
https://clinicaltrials.gov/ct2/show/NCT05369052

May 11th, 2022 - Approximately 865 subjects (519 contezolid acefosamil/contezolid: 346 linezolid) will be enrolled with moderate or severe DFI that are confirmed or suspected to be due to a Gram-positive bacterial pathogen (MITT analysis set).

Optimal Antibiotics for Operated Diabetic Foot Infections
https://clinicaltrials.gov/ct2/show/NCT04081792

Mar 29th, 2022 - Trial 1: At enrollment (Day 1), the investigator will prescribe empiric antibiotic treatment based on instructions provided in the protocol and determine the most appropriate route of administration (oral or IV) according to the patient's conditio...

Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections
https://clinicaltrials.gov/ct2/show/NCT04714411

Nov 17th, 2021 - This is a year-long study with planned enrollment of 57 patients (in addition to 114 historical control patients) evaluating the use of omadacycline for treatment of diabetic foot infections (DFI). Omadacycline (Nuzyra®) is a FDA approved antibiot...

see more →

News  36 results

EMA Panel Backs Two Antibacterials, Cefiderocol and Generic Tigecycline
https://www.medscape.com/viewarticle/925981

Mar 2nd, 2020 - At its February meeting, the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended two antibacterial agents: cefiderocol and a generic version of tigecycline. Cefiderocol (Fetcroja, Shionogi BV) is f...

Many patients with diabetic foot infections get unnecessary MRSA treatment
https://www.mdedge.com/familymedicine/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Dermatology News; Lucas Franki

Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.

Many patients with diabetic foot infections get unnecessary MRSA treatment
https://www.mdedge.com/diabeteshub/article/113703/infectious-diseases/many-patients-diabetic-foot-infections-get
Lucas Franki

Sep 13th, 2016 - Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates. Among the 318 patients with diabetic foot infections (DFIs) in the s.

Royal jelly
https://www.mdedge.com/dermatology/article/105627/aesthetic-dermatology/royal-jelly
Leslie S. Baumann, MD

Jan 7th, 2016 - Used for centuries by humans for its health-promoting qualities, royal jelly is a yellowish, viscous secretion from the hypopharyngeal and mandibular glands of worker bees that nourishes bee larvae of all kinds (i. e.

ICAAC: 2015 brings three major systematic reviews of diabetic foot infection therapy
https://www.mdedge.com/endocrinology/article/103042/diabetes/icaac-2015-brings-three-major-systematic-reviews-diabetic-foot
Bruce Jancin

Sep 26th, 2015 - SAN DIEGO – This has been a banner year for various expert panels to weigh in on the treatment of diabetic foot infections, with three major organizations each releasing systematic reviews. And all three in-depth reports reached the same conclusio.

see more →